Clinical Trials Browser

Interventional × Myeloid Malignancies × Clear all

NCT06930651 2026-03-11

A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies

Phase 1/2 Recruiting

Myeloid Malignancies

NCT06668584 2026-03-04

A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies

Phase 2 Recruiting

Myeloid Malignancies

NCT06917105 2025-04-08

Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Myeloid Malignancies

Phase 1/2 Not yet recruiting

Myeloid Malignancies

NCT04778410 2025-03-20

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

Phase 2 Terminated

54 enrolled 26 charts

Myeloid Malignancies

NCT02452697 2024-02-20

NK-DCI

Phase 2 Unknown

36 enrolled 11 charts

Myeloid Malignancies

NCT05807659 2023-04-11

Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies

Phase 2 Unknown

Myeloid Malignancies

NCT02958397 2019-06-25

A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies

Phase 1/2 Unknown

Myeloid Malignancies

NCT02958384 2018-01-23

A Clinical Research of LeY-Targeted CAR-T in Myeloid Malignancies

Phase 1/2 Unknown

Myeloid Malignancies